StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$0.11+0.00 (+1.81%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Cellyan Biotechnology net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2026 it was -$1.14M.

Annual net income

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$1.14M–
FY2025Mar 31, 2025-$27.06K-102.0%
FY2024Mar 31, 2024$1.33M+33.2%
FY2023Mar 31, 2023$998.20K–

More Cellyan Biotechnology figures

See a number that looks wrong?